News Opinion Editor's Corner TCT 2024 What’s Going to Be Big at TCT 2024? Michael O'Riordan October 17, 2024
News Opinion CV Team Dispatch September 2024 Dispatch for the CV Team L.A. McKeown September 01, 2024
News Daily News Burden of CVD Still High in UK Despite Prevention Efforts Over 20 Years Yael L. Maxwell June 26, 2024
News Daily News Diltiazem and DOAC Interaction Increases Bleeding Risk in AF L.A. McKeown April 18, 2024
News Opinion Editor's Corner TCTMD’s Top 10 Most Popular Stories for February 2024 Shelley Wood March 01, 2024
News Daily News BMI Mostly Doesn’t Impact DOACs, Except Maybe at the Extremes Todd Neale February 02, 2024
News Daily News GLP-1 Receptor Agonists Come With Broad Array of Benefits, Risks Todd Neale January 21, 2024
News Daily News Despite New Tools, PE Outcomes Remain Dire for Highest-Risk Patients L.A. McKeown January 02, 2024
News Daily News High-Sensitivity Troponins May Overestimate PE Severity L.A. McKeown November 28, 2023
News Conference News AHA 2023 NOW PUBLISHED - AZALEA-TIMI 71: Bleeds Plunge With Abelacimab vs Rivaroxaban in AF, but Stroke Impact Unclear L.A. McKeown November 12, 2023
Presentation TCT 2023 Market Expansion for Transcatheter Treatment of PE: Barriers and Potential Solutions Presenter: Andrew Sharp October 23, 2023
Presentation TCT 2023 The Thrombectomy Device Explosion: A Hospital/Health System’s Perspective Presenter: Dana Asato October 23, 2023
Presentation TCT 2023 Building the Clinical Evidence to Move The Field Forward: Current Challenges and Research Strategies Presenter: Peter Monteleone October 23, 2023
News Daily News ‘Overwhelming Reduction’ in Bleeding With Abelacimab vs Rivaroxaban in AF L.A. McKeown September 18, 2023